Title : Aromatase, aromatase inhibitors, and breast cancer.

Pub. Date : 2001 Sep-Oct

PMID : 11550075






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The potent and selective third-generation aromatase inhibitors anastrozole, letrozole, and exemestane are approved for clinical use as second-line endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies. Anastrozole cytochrome P450 family 19 subfamily A member 1 Homo sapiens